UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No. ________)*
MYOS RENS TECHNOLOGY INC.
(Name of Issuer)
Common Stock, par value $0.001 per share
(Title of Class of Securities)
554051201
(CUSIP Number)
April 25, 2018
(Date of Event which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
| ¨ | Rule 13d-1(b) |
| x | Rule 13d-1(c) |
| ¨ | Rule 13d-1(d) |
* The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
| CUSIP No. 554051201 | 13G | Page 2 of 4 Pages |
| 1. | NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) David J. Matlin |
||
| 2. | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (see instructions) (a) ¨ (b) ¨ |
||
| 3. | SEC USE ONLY |
||
| 4. | CITIZENSHIP OR PLACE OF ORGANIZATION United States |
| NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH |
5. | SOLE VOTING POWER 537,097 | |
| 6. | SHARED VOTING POWER 0 | ||
| 7. | SOLE DISPOSITIVE POWER 537,097 | ||
| 8. | SHARED DISPOSITIVE POWER 0 |
| 9. | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 537,097 |
| 10. | CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (see instructions) ¨ |
| 11. | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 8.29% |
| 12. | TYPE OF REPORTING PERSON (see instructions) IN |
| CUSIP No. 554051201 | 13G | Page 3 of 4 Pages |
Item 1(a). Name of Issuer.
MYOS RENS TECHNOLOGY INC. (the “Company”)
Item 1(b). Address of Issuer’s Principal Executive Offices:
The Company’s principal executive offices are located at 45 Horsehill Road, Suite 106 Cedar Knolls, New Jersey 07927.
Item 2(a). Name of Person Filing:
This statement is filed by David J. Matlin, hereinafter sometimes referred to as the “Reporting Person.”
Item 2(b). Address of the Principal Office or, if none, residence:
The address of the business office of Reporting Person is c/o MatlinPatterson Global Advisers LLC, 520 Madison Ave., 35th Fl., New York, NY 10022.
Item 2(c). Citizenship:
United States
Item 2(d). Title of Class of Securities:
Common Stock, par value $0.001 per share (the “Common Stock”).
Item 2(e). CUSIP Number:
554051201
Item 3. If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
Not applicable.
Item 4. Ownership.
The information required by Items 4(a) – (c) is set forth in Rows 5 – 11 of the cover page for the Reporting Person hereto and is incorporated herein by reference.
The percentage set forth in Row (11) of the cover page for the Reporting Person is based on an aggregate of 6,480,899 shares of Common Stock currently outstanding as reported in the Company’s Annual Report on Form 10-K for the year ended December 31, 2017 filed with the Securities and Exchange Commission on March 27, 2018.
| CUSIP No. 554051201 | 13G | Page 4 of 4 Pages |
Item 5. Ownership of Five Percent or Less of a Class.
Not applicable.
Item 6. Ownership of More than Five Percent on Behalf of Another Person.
Not applicable.
Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company.
Not applicable.
Item 8. Identification and Classification of Members of the Group.
Not applicable.
Item 9. Notice of Dissolution of Group.
Not applicable.
Item 10. Certification.
The Reporting Person hereby makes the following certification:
By signing below the Reporting Person certifies that, to the best his knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
| Date: May 2, 2018 | ||
| David J. Matlin | ||
| /s/ David J. Matlin |